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Species of the genus Hepatozoon are apicomplexan para-
sites transmitted by variety of hematophagous arthropods
to a wide range of intermediate hosts. Hepatozoon infec-
tions are broadly distributed around the world and the
presence of this parasite is confirmed both in cats and
dogs. Until now, two species from canines (H. canis, H.
americanum) and a single species from felines (H. felis)
have been reported. While the canine Hepatozoon spp. are
transmitted by ticks, the vector for H. felis remains
unknown. The aim of presented study was to determine
the prevalence and the diversity of Hepatozoon in popula-
tion of domestic cats and dogs living in close contact in
rural communities of Samburu pastoralists in northern
Kenya and to evaluate the existence of possible cross-
transmissions between both hosts. Between years 2007-
2012 in total, 135 and 258 blood samples from cats and
dogs from the area of Mt. Kulal (5 localities) was collected,
respectively. The DNA from blood (preserved in ethanol)
was extracted using phenol-chlorophorm method and fol-
lowed by conventional PCR screening. First round of PCR
was done by using Piroplasmid-F and Piroplasmid-R
primers, amplifying 18S rRNA gene of Hepatozoon spp.
(400 bp). A second PCR assay was performed in samples
positive by Piroplasmid primers to amplify a larger frag-
ment (1400 bp) of the 18S rRNA gene. All PCR amplicons
comming from positive samples were sequenced and
determined according to the BLAST match. In cats, this
revealed 110 out of 135 (81.5%) positive samples, of which
we obtained 104 sequences with an identity of 98% -100%
to an existing GenBank accession. In total, 77 sequences
were confirmed as Hepatozoon felis, 26 samples was
proven to be Hepatozoon sp. and a single sample was
determined as Hepatozoon canis with an identity of 96%.
Regarding dogs, 121 out of 258 (47%) were positive and
we gained 107 sequences of which 105 showed similarity
to Hepatozoon canis and the remaining two proved to
be Hepatozoon sp. Despite a close contact of hosts,
obviously cats and dogs do not share the same parasite,
which demonstrates a great majority of clearly identified
Hepatozoon canis/Hepatozoon felis. Mentioned facts could
be explained either by strict host specificity or by presence
of different vector or by both statements.
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